Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 6, 1996, Pages 560-565

  Huo, Teh Ia ^a   Wu, Jaw Ching ^a   Sheng, Wen Yung ^a   Chan, Cho Yu ^a   Hwang, Shinn Jang ^a   Chen, Trong Zong ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute liver failure; Hepatitis (viral); Multiple virus infection; Orthotopic liver transplantation.

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; CHOLESTEROL; CREATININE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SURVIVAL;

EID: 0029974314     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb01703.x     Document Type: Article

References (39)

1. Bismuth H, Samuel D, Gugenheim J et al. Emergent liver transplantation for fulminant hepatitis. Ann. Int. Med. 1987; 107: 337-41.
2. Peleman RR, Gavalar JS, Van Thiel D et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987; 7: 484-9.
3. Edmond J, Aran P, Whitington P, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583-8.
4. Vickers C, Neuberger J, Buckels J, McMaster P, Elias E. Transplantation of the liver in adults and children with fulminant hepatic failure. J. Hepatol. 1988; 7: 143-50.
5. Gimson AES, White YS, Eddlestone ALWF, William R. Clinical and prognostic differences in fulminant hepatitis A, B, non-A, non-B. Gut 1983; 24: 1194-8.
6. Raju GS, Brook S, Singh V, Mehta SK. Fulminant viral hepatitis: Indian experience. J. Gastroenterol. Hepatol. 1989; 4: 161-5.
7. Takahashi Y, Shimizu M, Fulminant Hepatitis Study Group. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentre study. J. Gastroenterol. Hepatol. 1991; 6: 159-64.
8. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: Evaluation of London and Clichy criteria. J. Hepatol. 1993; 17: 124-7.
9. O'Grady JG, Alexander GJM, Haylar K, William R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
10. Takahashi Y, Kumada H, Shimizu M et al. A multicenter study on the prognosis of fulminant viral hepatitis: Early prediction for liver transplantation. Hepatology 1994; 19: 1065-71.
11. Wu JS, Chen CH, Chiang YH et al. Hepatitis A virus infection in Taiwan. J. Formos. Med. Assoc. 1980; 79: 694-9.
12. Sung JL, Chen DS, Liaw YF et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chin. J. Gastroenterol. 1984; 1: 1-9.
13. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994; 107: 189-95.
14. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple virus infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: Application and limitations of the polymerase chain reaction. Hepatology 1994; 19: 836-40.
15. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: Definition and causes. Semin. Liver Dis. 1986; 6: 97-106.
16. Tong MJ, Sun SC, Shaeffer BT, Chang NK, Lo KJ, Peters RL. Hepatitis associated antigen and hepatocellular carcinoma in Taiwan. Ann. Int. Med. 1971; 75: 687-91.
17. Papaevangelou G, Tassopoulos N, Karayannis AR, Richardson C. Aetiology of fulminant viral hepatitis in Greece. Hepatology 1984; 4: 369-72.
18. Wright TL, Mamish D, Combs C et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339: 952-5.
19. Liang TJ, Jeffers L, Reddy RK et al. Fulminant or subfulminant non-A, non-B viral hepatitis: The role of hepatitis C and E virus. Gastroenterology 1993; 104: 556-62.
20. Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B hepatitis: Role of delta antigen. Gastroenterology 1984; 86: 1417-20.
21. Yanagi M, Kaneko S, Unoura M. Hepatitis C virus in fulminant hepatic failure. N. Engl. J. Med. 1991; 324: 1895-6.
22. Wu JC, Lee SD, Yeh PF et al. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers. Gastroenterology 1990; 98: 502-4.
23. Chu CM, Liaw YF. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: Increased risk in patients with pre-existing HBsAg carrier state. Infection 1990; 18: 200-3.
24. Chu CM, Sheen IS, Liaw YF. The aetiology of acute hepatitis in Taiwan: Acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier state. Infection 1988; 16: 233-7.
25. Chu CM, Liaw YF, Pao CC, Huang MJ. The aetiology of acute hepatitis upon previously unrecognized HBsAg carriers. Hepatology 1989; 9: 452-6.
26. Liaw YF, Chien RN, Chen TJ, Sheen IS, Chu CM. Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection. J. Med. Virol. 1992; 37: 294-7.
27. O'Grady JG, Schalm SW, William R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
28. Acharya SK, Dasarathy S, Tandon BN. Should we redefine acute liver failure? Lancet 1993; 342: 1421-22.
29. Bernuau J, Samuel D, Durand F. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: A prospective study. Gastroenterology 1991; 14: 49A (Abstract).
30. Karvountzis GG, Redeker AG. Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann. Int. Med. 1974; 80: 156-60.
31. Sheen IS, Chu CM, Liaw YF. Fulminant viral hepatitis: A clinical study. J. Formo. Med. Assoc. 1986; 85: 679-86.
32. Bloomer JR, Waldmann TA, McIntire KR, Klastin G. Relationship of serum α-fetoprotein to the severity and duration of illness in patients with viral hepatitis. Gastroenterology 1975; 68: 342-50.
33. Bloomer JR, Waldmann TA, McIntire KR, Klastin G. Serum α-fetoprotein in patients with massive hepatic necrosis. Gastroenterology 1977; 72: 479-82.
34. Van Thiel DH. When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: At admission to hospital or when a donor organ is made available? J. Hepatol. 1993; 17: 1-2.
35. Gallinger S, Greig PD, Blendis LM et al. Liver transplantation for acute and subacute fulminant hepatic failure. Transplant. Proc. 1989; 21: 2435-8.
36. Iwatsuki S, Stieber AC, Marsh JW et al. Liver transplantation for fulminant hepatic failure. Transplant. Proc. 1989; 21: 2431-4.
37. Christensen E, Bremmelgaard A, Bahnsen M, Buch Andreasen P, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand. J. Gastroenterol. 1984; 19: 90-96.
38. Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 1993; 329: 1842-7.
39. Villamil FG, Pan S-H, Kuhns MC. Efficacy and cost of long-term intramuscular hepatitis B immunoglobulin in liver transplantation for hepatitis B. Hepatology 1994; 20: 129A.